Name | Oxcarbazepine |
Synonyms | Oxetol Aurene Oxecarb TRILEPTAL Oxcarbazepine 10,11-DIHDYRO-10-OXO-5H-DIBENZ[B,F]AZEPINE-5-CARBOXAMIDE 10,11-DIHYDRO-10-OXO-5H-DIBENZ[B,F]AZEPINE-5-CARBOXAMIDE 10,11-dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide 10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide 5H-DIBENZ[B,F]AZEPINE-5-CARBOXAMIDE, 10,11-DIHYDRO-10-OXO- Oxcarbazepine 10,11-Dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide |
CAS | 28721-07-5 |
EINECS | 249-188-8 |
InChI | InChI=1/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19) |
Molecular Formula | C15H12N2O2 |
Molar Mass | 252.27 |
Density | 1.329±0.06 g/cm3(Predicted) |
Melting Point | 215-216°C |
Boling Point | 457.2±55.0 °C(Predicted) |
Flash Point | 230.3±31.5 °C |
Water Solubility | Soluble in DMSO, methanol, water, ethanol and acetone. |
Solubility | Soluble in DMSO, methanol, water, ethanol and acetone. |
Vapor Presure | 1.52E-08mmHg at 25°C |
Appearance | Light brown crystal |
Color | white |
Merck | 14,6929 |
pKa | 13.73±0.20(Predicted) |
Storage Condition | Sealed in dry,Room Temperature |
Refractive Index | 1.661 |
MDL | MFCD00865307 |
Physical and Chemical Properties | Appearance: light brown crystal Melting Point: 216-222 ℃ |
Use | Nervous system medication |
Risk Codes | R22 - Harmful if swallowed R36 - Irritating to the eyes R20/21/22 - Harmful by inhalation, in contact with skin and if swallowed. R11 - Highly Flammable |
Safety Description | S16 - Keep away from sources of ignition. S36/37 - Wear suitable protective clothing and gloves. |
UN IDs | UN 1648 3 / PGII |
WGK Germany | 3 |
RTECS | HN8445000 |
HS Code | 29339900 |
Reference Show more | 1. Fan Liju, quiet, Cui Yanjun, Dong Zhanjun. Determination of 5 psychotropic drugs in human plasma by UPLC-MS/MS [J]. Chinese Journal of Clinical Pharmacology, 2020,36(22):3807-3810. |
crystallized from ethanol, melting point 215-216 °c.
10-methoxy-5h-= benzo [B, f] azepine and phosgene were reacted in toluene. The obtained compound was dissolved in ethanol, ammonia gas was introduced under reflux, and finally, it was refluxed in hydrochloric acid to obtain oxcarbazepine.
developed by the Swiss company Ciba-Geigy, launched in September 1991. For anti-epilepsy. Both oxcarbazepine and its in vivo metabolite hydroxy derivatives have anticonvulsant activity. It can be used for localized and generalized seizures. Carbamazepine is a derivative of carbamazepine, the same role and carbamazepine, but less side effects, no adverse drug interactions.